Incorporates an active component that will significantly shorten the treatment duration of MPE compared to current catheter devices.
A user-friendly design to promote patient independence, comfort and quality of life.
Reduces the costs associated with long-term home drainage and acute readmissions to hospital.
Posted in News by Mary Faherty
4th May, 2022
SymPhysis Medical were thrilled to win the MedTech Innovator Dublin International Pitch event, which took place in Dublin on 25 & 26 April 2022. MedTech Innovator is a global competition and...
Read more
Posted in News by Symphysis Medical
28th February, 2022
SymPhysis Medical is delighted to be included in the Health Innovation Hub Ireland (HIHI) 20 Health Innovations to watch for 2022. The Innovation Showcase was launched by Taoiseach Mr Micheál Martin...
Read more
Posted in News by Mary Faherty
12th January, 2022
An exciting new collaboration is underway in the West of Ireland, bringing disruptive technology into the palliative care space. A consortium of four organisations have joined forces to bring to market...
Read more
Posted in News by Symphysis Medical
4th January, 2022
The SymPhysis Medical team has been working with the National Innovation Centre for Ageing (NICA) at their hub of innovation, The Catalyst, in Newcastle-Upon-Tyne in the UK. In December, the...
Read more
Affects ~90% of patients with mesothelioma.
Affects ~ 35% of patients with lung cancer.
Affects ~ 16% of patients with breast cancer.
Affects ~ 11% of patients with lymphoma.
